In future work, the association between the NLRP3 inflammasome and teneligliptin in diabetes-related CI will be identified by co-administering the diabetic mice with teneligliptin and the agonist of the NLRP3 inflammasome. The gene discussed is NLRP3; the disease is diabetes mellitus.